CDMS

Lotus Clinical Research Expands Partnership with Veeva to Accelerate Clinical Trials

Retrieved on: 
Tuesday, May 30, 2023
Partnership, CNS, CTMS, Veeva Systems, Documentation, CDMS, Pain, Knowledge, Growth, NYSE, Lotus, EDC, Pharmaceutical industry, Nursing

NEW PROVIDENCE, N.J. and PLEASANTON, Calif., May 30, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Lotus Clinical Research expanded its partnership with Veeva and broadened its adoption of Veeva Vault Clinical Suite, a strategic move to strengthen its service delivery and efficiency. This builds on Lotus' existing use of Vault Clinical Suite to implement swifter and more connected studies. The successful incorporation of Veeva Vault CDMS, Veeva Vault eTMF, and Veeva Vault CTMS has effectively scaled Lotus' trial operations while sustaining the highest quality standards. With a unified clinical ecosystem, Lotus has significantly reduced study startup time.

Key Points: 
  • NEW PROVIDENCE, N.J. and PLEASANTON, Calif., May 30, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Lotus Clinical Research expanded its partnership with Veeva and broadened its adoption of Veeva Vault Clinical Suite , a strategic move to strengthen its service delivery and efficiency.
  • The successful incorporation of Veeva Vault CDMS , Veeva Vault eTMF , and Veeva Vault CTMS has effectively scaled Lotus' trial operations while sustaining the highest quality standards.
  • Lotus President, Bill Martin, elaborated on the benefits of the partnership with Veeva, "This collaboration enables Lotus to conduct a higher volume of clinical trials while improving coordination with sponsors and clinical trial sites.
  • "We're proud to grow our five-plus year partnership with Lotus, bringing together their experience and knowledge executing complex clinical trials with our technology expertise," said Jon Young, director, Veeva Vault Clinical strategy.

Lotus Clinical Research Expands Partnership with Veeva to Accelerate Clinical Trials

Retrieved on: 
Tuesday, May 30, 2023
Partnership, CNS, CTMS, Veeva Systems, Documentation, CDMS, Pain, Knowledge, Growth, NYSE, Lotus, EDC, Pharmaceutical industry, Nursing

NEW PROVIDENCE, N.J. and BARCELONA, Spain, May 30, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Lotus Clinical Research expanded its partnership with Veeva and broadened its adoption of Veeva Vault Clinical Suite, a strategic move to strengthen its service delivery and efficiency. This builds on Lotus' existing use of Vault Clinical Suite to implement swifter and more connected studies. The successful incorporation of Veeva Vault CDMS, Veeva Vault eTMF, and Veeva Vault CTMS has effectively scaled Lotus' trial operations while sustaining the highest quality standards. With a unified clinical ecosystem, Lotus has significantly reduced study startup time.

Key Points: 
  • NEW PROVIDENCE, N.J. and BARCELONA, Spain, May 30, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Lotus Clinical Research expanded its partnership with Veeva and broadened its adoption of Veeva Vault Clinical Suite , a strategic move to strengthen its service delivery and efficiency.
  • The successful incorporation of Veeva Vault CDMS , Veeva Vault eTMF , and Veeva Vault CTMS has effectively scaled Lotus' trial operations while sustaining the highest quality standards.
  • Lotus President, Bill Martin, elaborated on the benefits of the partnership with Veeva, "This collaboration enables Lotus to conduct a higher volume of clinical trials while improving coordination with sponsors and clinical trial sites.
  • "We're proud to grow our five-plus year partnership with Lotus, bringing together their experience and knowledge executing complex clinical trials with our technology expertise," said Jon Young, director, Veeva Vault Clinical strategy.

eClinical Solutions Market worth $17.9 billion in 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, January 30, 2023
RIMS, American Opportunity Tax Credit, CDMS, EHR, CTMS, Veeva Systems, EDC, Electronic, Informal economy, Growth, Hospital, IBM, Oracle Corporation, Android, Medicine, Openclinica, Row, Clinical data management, SAAS, NeoGenomics, Merative, Investment, Dassault Group, IOS, Medical imaging, Medical device, Parexel, Medidata Solutions

Based on delivery mode, the global eClinical solutions market is segmented into licensed enterprise (on-premises) models, web-hosted (on-demand) models, and cloud-based (SAAS) models.

Key Points: 
  • Based on delivery mode, the global eClinical solutions market is segmented into licensed enterprise (on-premises) models, web-hosted (on-demand) models, and cloud-based (SAAS) models.
  • The cloud-based eClinical solutions segment is estimated to register the highest CAGR of 17.8% during the forecast period.
  • The pharmaceutical & biopharmaceutical companies segment accounted for the largest share (38.5%) of the eClinical solutions market in 2021.
  • The global eClinical solutions market is segmented into four major regions: North America, Europe, Asia Pacific, and the Rest of the World (RoW).

eClinical Solutions Market worth $17.9 billion in 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, January 30, 2023
RIMS, American Opportunity Tax Credit, CDMS, EHR, CTMS, Veeva Systems, EDC, Electronic, Informal economy, Growth, Hospital, IBM, Oracle Corporation, Android, Medicine, Openclinica, Row, Clinical data management, SAAS, NeoGenomics, Merative, Investment, Dassault Group, IOS, Medical imaging, Medical device, Parexel, Medidata Solutions

Based on delivery mode, the global eClinical solutions market is segmented into licensed enterprise (on-premises) models, web-hosted (on-demand) models, and cloud-based (SAAS) models.

Key Points: 
  • Based on delivery mode, the global eClinical solutions market is segmented into licensed enterprise (on-premises) models, web-hosted (on-demand) models, and cloud-based (SAAS) models.
  • The cloud-based eClinical solutions segment is estimated to register the highest CAGR of 17.8% during the forecast period.
  • The pharmaceutical & biopharmaceutical companies segment accounted for the largest share (38.5%) of the eClinical solutions market in 2021.
  • The global eClinical solutions market is segmented into four major regions: North America, Europe, Asia Pacific, and the Rest of the World (RoW).

Global eClinical solutions Market Report 2022 to 2028: Rising Adoption of Software Solutions in Clinical Trails Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 10, 2023
Technology, Software, Cloud, Hospital, CTMS, COVID-19, Calendar, Maintenance, Drug development, Organization, Marketing, Growth, CDMS, Patient, Clinical data management, Clinical trial, Pharmaceutical industry, Medical imaging

The Global eClinical solutions Market size is expected to reach $20.1 billion by 2028, rising at a market growth of 13.6% CAGR during the forecast period.

Key Points: 
  • The Global eClinical solutions Market size is expected to reach $20.1 billion by 2028, rising at a market growth of 13.6% CAGR during the forecast period.
  • With professional data services as well as the elluminate Clinical Data Cloud, eClinical Solutions assists life sciences enterprises all over the world in accelerating clinical development projects.
  • The eClinical solutions market is concentrating on the development and marketing of software solutions that help speed up and efficiently complete clinical studies.
  • Many integrated eClinical solutions (like CTMS and CDMS) offer clinical researchers end-to-end solutions for all phases of clinical trial administration.

Certis Biologicals Elevates Leadership for U.S.-Based Sales Efforts

Retrieved on: 
Monday, November 21, 2022
Agriculture, Natural Resources, Sustainability, Environment, Other Manufacturing, Chemicals, Plastics, Green Technology, Manufacturing, Investment, Marketing, CDMS, Multimedia, Social media, Caterpillar Inc., Biologicals, China Biologic Products, Growth, Natural Resources, Certis Group, American Cyanamid

Certis Biologicals today announced that veteran sales leader Tim Riley has been tapped to helm the companys U.S.-based sales team as National Sales Director for U.S. Ag Business.

Key Points: 
  • Certis Biologicals today announced that veteran sales leader Tim Riley has been tapped to helm the companys U.S.-based sales team as National Sales Director for U.S. Ag Business.
  • View the full release here: https://www.businesswire.com/news/home/20221121005698/en/
    Certis Biologicals today announced that veteran sales leader Tim Riley has been tapped to helm the companys U.S.-based sales team as National Sales Director for U.S. Ag Business.
  • (Photo: Business Wire)
    Riley joined Certis Biologicals in 2020 as Key Account Manager, supporting the companys business partnerships with distribution leaders.
  • As National Sales Director, he will continue those efforts by managing the companys nationwide team of sales managers and key accounts.

Global eClinical Solutions Market Report 2022: Rising Research and Development Activities by Biopharma and Pharma Companies Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 15, 2022
Health, Technology, Other Health, Software, Clinical Trials, Biotechnology, Cloud, Investment, CTMS, Observation, Academic institution, Geography, Xoom (web hosting), SWOT, Ansoff Matrix, CDMS, Clinical, EDC, Market development, COVID-19, ECOA, Growth, Porter's five forces analysis, Risk, Medical device, Retail, Risk management, Pharmaceutical industry, Hospital

By Development Phase, the market is classified into Phase I, Phase II, Phase III, and Phase IV.

Key Points: 
  • By Development Phase, the market is classified into Phase I, Phase II, Phase III, and Phase IV.
  • By End-Users, the market is classified into Academic Institutes, Hospitals, Medical Device Manufacturers, Pharma & Biotech Organizations, and Contract Research Organizations.
  • The report presents a detailed Ansoff matrix analysis for the Global eClinical Solutions Market.
  • The report offers a comprehensive evaluation of the Global eClinical Solutions Market.

Commission for Case Manager Certification issues call for comments on revised Codes of Professional Conduct for Certified Case Managers and Certified Disability Management Specialists

Retrieved on: 
Wednesday, November 16, 2022
Ethics, Health, Certification, Code, Safety, Documentation, Association, Privacy, CDMS, Case management (US healthcare system), MPA, CCM, Commission, CAE, RN, Complaint, CEO, Professional practice of behavior analysis, Case management, Review, Language, Property management, Public relations, Medicine, Audit

MOUNT LAUREL, N.J., Nov. 16, 2022 /PRNewswire/ -- The Commission for Case Manager Certification® (the Commission), which oversees certification for more than 50,000 board-certified case managers and disability management specialists nationwide, seeks input from certified case managers (CCM), certified disability management specialists (CDMS) and other interested parties on its revised CCM® and CDMS® Codes of Professional Conduct (the Codes). The deadline for public comment is December 14, 2022.

Key Points: 
  • MOUNT LAUREL, N.J., Nov. 16, 2022 /PRNewswire/ -- The Commission for Case Manager Certification (the Commission), which oversees certification for more than 50,000 board-certified case managers and disability management specialists nationwide, seeks input from certified case managers (CCM), certified disability management specialists (CDMS) and other interested parties on its revised CCM and CDMS Codes of Professional Conduct (the Codes).
  • The proposed Code of Professional Conduct for Case Managers is available for review at this link , and the proposed Code of Professional Conduct for Certified Disability Management Specialists can be viewed here .
  • The Commission for Case Manager Certification is the first and largest nationally accredited case management certification organization, credentialing more than 50,000 professional case managers and disability management specialists.
  • Offering an extensive portfolio of certification and professional advancement activities, the Commission is the most active and prestigious certification organization supporting the practices of case management and disability management.

Commission for Case Manager Certification highlights vital role of case managers during 2022 National Case Management Week

Retrieved on: 
Thursday, October 6, 2022
Magnet, Uncertainty, Occupational burnout, Certification, Commission, Education, Family, Case management (US healthcare system), Association of Official Seed Certifying Agencies, Case management, National Commission, Twitter, CDMS, Workforce, Symposium, Empowerment, Nursing, Symposium (Plato), Facebook, Social work, Knowledge, Goal, Disability, Learning, Industry, CEO, CCM, Evidence-based practice, Celebrate Me Home (song), CCMC, Public health, Medicine, Public relations

MOUNT LAUREL, N.J., Oct. 6, 2022 /PRNewswire-PRWeb/ -- The Commission for Case Manager Certification® today affirmed its dedication to exceptional case management by announcing personal and professional development tools during National Case Management Week, Oct. 9-15, 2022—including the 2022 Virtual Symposium from Oct. 11-13 and a new season of its "Push Pause" self-care series. The Commission offers workforce development resources for today's case manager. Over the past two years, the Commission has provided tools to cultivate self-assurance and achieve balance so professional case managers can thrive personally and professionally.

Key Points: 
  • The Commission commends board-certified case managers and disability management specialists for their immense adaptability in the last two years.
  • "The professional case manager role has evolved rapidly in intensely challenging ways," said MaryBeth Kurland, CEO of the Commission.
  • The Commission for Case Manager Certification is the first and largest nationally accredited case management certification organization, credentialing more than 50,000 professional case managers and disability management specialists.
  • Offering an extensive portfolio of certification and professional advancement activities, the Commission is the most active and prestigious certification organization supporting the practices of case management and disability management.

Case management organizations announce unified case management definition and joint advisory task force

Retrieved on: 
Tuesday, September 20, 2022
Case management, Certification, Health, CDMS, Transition, Twitter, Nursing, Social, ROCK, Legislation, Association, Organization, Face, Industry, Health equity, Facebook, Physician, CCM, Case management (US healthcare system), Solution, Human, ACMA, Commission, Education, CCMC, Medicine

LITTLE ROCK, Ark., September 20, 2022 /PRNewswire-PRWeb/ --The American Case Management Association (ACMA) and the Commission for Case Management Certification (CCMC) today announced a unified definition for case management and the creation of a joint Advocacy Task Force.

Key Points: 
  • LITTLE ROCK, Ark., September 20, 2022 /PRNewswire-PRWeb/ --The American Case Management Association (ACMA) and the Commission for Case Management Certification (CCMC) today announced a unified definition for case management and the creation of a joint Advocacy Task Force.
  • About the American Case Management Association:
    Founded in 1999, the American Case Management Association (ACMA) is a national, non-profit, professional membership association, which strives to provide resources, solutions, and support for Case Management and Transitions of Care professionals.
  • About the Commission for Case Manager Certification:
    The Commission for Case Manager Certification is the first and largest nationally accredited case management certification organization, credentialing more than 50,000 professional case managers and disability management specialists.
  • Offering an extensive portfolio of certification and professional advancement activities, the Commission is the most active and prestigious certification organization supporting the practices of case management and disability management.